RELENZA

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
21-03-2017

Toimeaine:

ZANAMIVIR MICRONIZED

Saadav alates:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC kood:

J05AH01

Ravimvorm:

POWDER FOR INHALATION

Koostis:

ZANAMIVIR MICRONIZED 5 MG

Manustamisviis:

INHALATION

Retsepti tüüp:

Required

Valmistatud:

GLAXO SMITH KLINE AUSTRALIA PTY LTD

Terapeutiline rühm:

ZANAMIVIR

Terapeutiline ala:

ZANAMIVIR

Näidustused:

Zanamivir is indicated for the treatment of both uncomplicated acute illness due to influenza A and B virus in adults and adolescents (> or = 12 years) who have been symptomatic for no more than 48 hours and pediatric patients 7 years and older who have been symptomatic for no more than 36 hours.

Loa andmise kuupäev:

2017-03-26

Otsige selle tootega seotud teateid

Vaadake dokumentide ajalugu